PUBLISHER: Grand View Research | PRODUCT CODE: 2152189
PUBLISHER: Grand View Research | PRODUCT CODE: 2152189
The global breast ultrasound market size was estimated at USD 2.6 billion in 2025 and is projected to grow from USD 3.0 billion in 2026 to USD 7.6 billion by 2033, growing at a CAGR of 14.2% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 35.0% in 2025. The increasing incidence of breast cancer, rise in demand for breast ultrasound, technological advancements, and various awareness initiatives undertaken by the governments and non-profit organizations are among the factors driving the market growth.
According to an article published by NBC UNIVERSAL in April 2024, experts from the U.S. Preventive Services Task Force (USPSTF) recommended that people with breasts undergo an annual mammogram starting at age 40. The rising prevalence of breast cancer across the globe is anticipated to fuel product demand. Cancer is one of the leading causes of death globally, and breast cancer is the second most common cancer worldwide. In the case of women, breast cancer tops the list of most prevalent cancers.
Rise in sedentary lifestyle, obesity, and changes in eating habits are some of the major factors contributing to breast cancer. Moreover, rising alcohol consumption is also expected to increase the risk of disease. The risk increases by around 7% to 10% per unit of alcohol consumption per day. Such an increasing prevalence of the disease is expected to boost the demand for breast ultrasound shortly.
Due to the rising demand for the prevention and treatment of this disease, key companies and research organizations are launching technologically advanced products to strengthen their foothold in the breast ultrasound market. Furthermore, the American Cancer Society's Cancer Facts & Figures 2025 estimated that more than 316,950 new invasive breast cancer cases would be diagnosed among women in the U.S. in 2025, underscoring the continued need for advanced breast imaging technologies.
In addition, the growing prevalence of dense breast tissue among women and increasing awareness regarding supplemental screening are further driving market growth. Mammography often has reduced sensitivity in women with dense breast tissue, making breast ultrasound an important complementary imaging modality for early lesion detection. According to the U.S. FDA's breast density notification rule, effective September 2024, mammography facilities are required to inform patients about breast density, increasing awareness regarding supplemental screening options such as breast ultrasound. This regulatory development is expected to support the adoption of breast ultrasound over the forecast period.
Global Breast Ultrasound Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global breast ultrasound market report based on product, end use, and region:
Conventional Breast Ultrasound (CBUS)
Automated Breast Ultrasound (ABUS)
Hospital
Diagnostics Imaging Laboratories
Others
North America
Europe
Asia Pacific
Latin America
Middle East and Africa (MEA)